title: A new dawn for gemtuzumab ozogamicin?
authors.affiliation: Departments of Blood and Marrow Transplantation and Oncologic Sciences, H Lee Moffitt Cancer Center, University of South Florida College of Medicine, Tampa, FL 33612, USA. Electronic address: mohamed.kharfan-dabaja@moffitt.org.
authors.forename: Mohamed A
authors.initials: MA
authors.lastname: Kharfan-Dabaja
mesh_terms: D000617:Aminoglycosides / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D005260:Female; D000079982:Gemtuzumab; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality*; D008297:Male
chemical_list: D000617:Aminoglycosides; D061067:Antibodies, Monoclonal, Humanized; D000079982:Gemtuzumab